Free Trial

Contineum Therapeutics (CTNM) SEC Filings & 10K Form

Contineum Therapeutics logo
$3.86 +0.01 (+0.13%)
As of 12:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Contineum Therapeutics SEC Filings

DateFilerForm TypeView
05/14/2025
3:41 PM
Contineum Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/14/2025
3:44 PM
Contineum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
3:47 PM
Contineum Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/29/2025
3:53 PM
Contineum Therapeutics (Filer)
Form ARS
04/29/2025
3:14 PM
Contineum Therapeutics (Filer)
Form DEFA14A
04/28/2025
3:10 PM
Contineum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
3:08 PM
Contineum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
3:10 PM
Contineum Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2025
3:13 PM
Contineum Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
9:50 AM
Contineum Therapeutics (Subject)
SECTORAL ASSET MANAGEMENT INC (Filed by)
Form SCHEDULE 13G/A
01/31/2025
3:35 PM
Contineum Therapeutics (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:38 PM
Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:38 PM
Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:40 PM
Contineum Therapeutics (Issuer)
Slover Peter T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:06 PM
Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
4:07 PM
Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:05 PM
Contineum Therapeutics (Subject)
Lorrain Daniel S. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:08 PM
Contineum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Contineum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
11:46 AM
Contineum Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G
08/14/2024
5:03 PM
Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
11:46 AM
Contineum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
11:19 AM
Contineum Therapeutics (Filer)
Form 8-K/A
06/24/2024
3:20 PM
Boyce Sarah (Reporting)
Contineum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2024
3:25 PM
Boyce Sarah (Reporting)
Contineum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:43 PM
Contineum Therapeutics (Issuer)
Healy John Stephen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/03/2024
4:46 PM
Contineum Therapeutics (Issuer)
Healy John Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:53 PM
Contineum Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:54 PM
Brady Todd R. (Reporting)
Contineum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:54 PM
Contineum Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:55 PM
Contineum Therapeutics (Issuer)
Ware Olivia C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:56 PM
Contineum Therapeutics (Issuer)
Ignelzi Troy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:56 PM
Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:58 PM
Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:58 PM
Contineum Therapeutics (Issuer)
Slover Peter T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:59 PM
Contineum Therapeutics (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CTNM) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners